TY - JOUR T1 - Patients with Rheumatoid Arthritis in Remission While Receiving Etanercept Plus Methotrexate Therapy May Require Adjustment of Dosing Regimen When Switched to Methotrexate Monotherapy JF - The Journal of Rheumatology JO - J Rheumatol SP - 259 LP - 259 DO - 10.3899/jrheum.160815 VL - 44 IS - 2 AU - BERNARD BANNWARTH Y1 - 2017/02/01 UR - http://www.jrheum.org/content/44/2/259.1.abstract N2 - To the Editor:I read with interest the article by Wiland, et al1 reporting on patients with early moderate to severe rheumatoid arthritis who achieved remission while receiving etanercept (ETN) 50 mg once weekly (QW) plus methotrexate (MTX). They experienced significant worsening in patient-reported outcome (PRO) measures when switched to placebo or … ER -